EC approves AstraZeneca’s Tagrisso with chemotherapy for EGFR-mutated lung cancer

AstraZeneca has received approval from the European Commission (EC) to use its cancer drug, Tagrisso (osimertinib), in combination with pemetrexed and platinum-based chemotherapy as a ... Read More